Paper

Design of a broadly reactive Lyme disease vaccine

Published May 1, 2020 · H. Kamp, K. Swanson, R. Wei

NPJ Vaccines

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Rigorous Journal

Study Snapshot

This multivalent Lyme disease vaccine effectively elicits antibody responses against all major Borrelia strains, offering potential to limit the spread of the disease.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Design of a broadly reactive Lyme disease vaccine

References

Citations